Porosome.AI

Porosome.AI is a biotechnology company pioneering the development of therapeutics that target the porosome, the universal secretory portal in cells. The company leverages a proprietary platform combining high-resolution imaging, functional proteomics, and artificial intelligence to identify and modulate the molecular machinery of secretion. Their research focuses on diseases characterized by secretory defects, including cystic fibrosis, diabetes, and neurological disorders like Alzheimer's. By restoring or enhancing cellular secretion, Porosome.AI aims to address the root causes of these conditions rather than just managing symptoms. The company's approach represents a novel paradigm in drug discovery centered on the fundamental mechanism of cellular communication and transport.